Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas

Hepatobiliary and Pancreatic Diseases International

Volumn 7, Issue 1, 2008, Pages 86-90

  Kashima, Kyoko ^a,b,c   Ohike, Nobuyuki ^a   Mukai, Seishiro ^a   Sato, Masashi ^a   Takahashi, Manabu ^a   Morohoshi, Toshio ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY KOTO TOYOSU HOSPITAL   (Japan)

^c Department of Dentistry Oral surgery   (Japan)

Author keywords

Apoptosis; Immunohistochemistry; Intraductal papillary mucinous neoplasm; Maspin; Pancreas

Indexed keywords

MASPIN;

APOPTOSIS; ARTICLE; CANCER GRADING; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; PANCREAS ADENOMA; PANCREAS CARCINOMA; SCORING SYSTEM; TUMOR CELL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, MUCINOUS; ADENOMA; AGED; APOPTOSIS; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; SERPINS;

EID: 39049171799     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263:526-529.
2. Jiang N, Meng Y, Zhang S, Mensah-Osman E, Sheng S. Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 2002;21:4089-4098.
3. Li Z, Shi HY, Zhang M. Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis. Oncogene 2005;24:2008-2019.
4. Maass N, Hojo T, Rosel F, Ikeda T, Jonat W, Nagasaki K. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem 2001;34:303-307.
5. Hojo T, Akiyama Y, Nagasaki K, Maruyama K, Kikuchi K, Ikeda T, et al. Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues. Cancer Lett 2001;171:103-110.
6. Maass N, Teffner F, Rosel F, Pawaresch R, Jonat W, Nagasaki K, et al. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumor progression in ductal carcinomas of the breast. J Pathol 2001;195:321-326.
7. Machtens S, Serth J, Bokemeyer C, Bathke W, Minssen A, Kollmannsberger C, et al. Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer 2001;95:337-342.
8. Zou Z, Zang W, Young D, Gleave MG, Rennie P, Connell T, et al. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of maspin expression by androgen ablation. Clin Cancer Res 2002;8:1172-1177.
9. Maass N, Biallek M, Rosel F, Schem C, Ohike N, Zhang M, et al. Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem Biophys Res Commun 2002;297:125-128.
10. Sugimoto S, Maass N, Takimoto Y, Sato K, Minei S, Zhang M, et al. Expression and regulation of tumor suppressor gene maspin in human bladder cancer. Cancer Lett 2004; 203:209-215.
11. Futscher BW, Oshiro MM, Wozniak RJ, Holten N, Hanigan CL, Duan H, et al. Role for DNA methylation in the control of cell type-specific maspin expression. Nat Genet 2002; 31:175-179.
12. Ohike N, Maass N, Mundhenke C, Biallek M, Zhang M, Jonat W, et al. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. Cancer Lett 2003;199:193-200.
13. Oh YL, Song SY, Ahn G. Expression of maspin in pancreatic neoplasms: application of maspin immunohistochemistry to the differential diagnosis. Appl Immunohistochem Mol Morphol 2002;10:62-66.
14. Maass N, Hojo T, Ueding M, Luttges J, Kloppel G, Jonat W, et al. Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res 2001;7:812-817.
15. Cao D, Zhang Q, Wu LS, Salaria SN, Winter JW, Hruban RH, et al. Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Mod Pathol 2007;20:570-578.
16. Hruban R, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-586.
17. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977-987.
18. Song SY, Lee SK, Kim DH, Son HJ, Kim HJ, Lim YJ, et al. Expression of maspin in colon cancers: its relationship with p53 expression and microvessel density. Dig Dis Sci 2002; 47:1831-1835.
19. Xia W, Lau YK, Hu MC, Li L, Johnston DA, Sheng S, et al. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 2000;19:2398-2403.
20. Yasumatsu R, Nakashima T, Hirakawa N, Kumamoto Y, Kuratomi Y, Tomita K, et al. Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck 2001;23:962-966.
21. Nakashima M, Ohike N, Nagasaki K, Adachi M, Morohoshi T. Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma. J Cancer Res Clin Oncol 2004;130:475-479.
22. Ushio J, Ohike N, Kojima M, Nagasaki K, Matsukawa M, Morohoshi T. Expression of the tumor suppressor gene maspin in early gastric carcinoma and its significance: significant correlation with vascular invasion. Showa Univ J Med Sci 2006;18:13-18.
23. Salvia R, Fernandes-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004;239:678-685.
24. Latha K, Zhang W, Cella N, Shi HY, Zhang M. Maspin increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol Cell Biol 2005; 25:1737-1748.
25. Budihardjo I, Oliver H, Lutter M, Luo X, Wang Z. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999;15:269-290.
26. Adsay NV, Merati K, Basturk O, Iacobuzio-Donahue C, Levi E, Cheng JD, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004;28:839-848.
27. Yonezawa S, Nakamura A, Horinouchi M, Sato E. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J Hepatobiliary Pancreat Surg 2002;9:328-341.
28. Lüttges J, Zamboni G, Longnecker D, Kloppel G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001;25:942-948.